Table 2.

Reversible cerebral vasoconstriction syndrome (RCVS) versus other acute angiographically defined central nervous system vasculopathies. Data are mean (range) or proportions.

VariableRCVSControlp
No. cases1311
Female (%)12/13 (92)8/11 (72)0.30
Age, yrs (range)52.9 (21–71)48.6 (26–60)0.19
Disease course, days
  Time to admission3.7 (0–13)3.3 (0–17)0.42
  Time to angiography9.4 (2–26)10 (1–25)1
  Length of stay15 (4–31)20 (7–38)0.42
Clinical findings (%)
  Headaches
    Overall13/13 (100)8/11 (73)0.08
    Thunderclap headache10/13 (77)2/11 (18)0.01
    Acute2/13 (15)4/11 (36)
    Other1/13 (8)2/11 (18)
  Focal deficit7/13 (54)11/11 (100)0.02
  Focal deficit > 24 h5/7 (71)10/11 (91)0.53
  Fever0/13 (0)3/11 (27)0.08
  Emesis5/13 (38)5/11 (45)1
  Altered vigilance2/13 (15)6/11 (55)0.08
  Rankin score0.04
    1–210/13 (77)3/11 (27)
    3–53/13 (23)8/11 (73)
Laboratory findings
  Mean CSF white blood cells /mm3 (range)4 (0–45)274 (1–1800)0.19
  CSF WBC > 10/mm3 (%)1/10 (10)3/9 (33)0.30
  Mean CSF protein, g/l (range)0.51 (0.3–1)1.07 (0.2–4)0.59
  CSF protein > 0.5 g/l (%)4/10 (40)5/9 (55)0.66
Brain MRI (%)
  Abnormal10/13 (77)11/11 (100)0.22
  cSAH8/13 (61)0/11 (0)0.006
  Stroke4/13 (31)11/11 (100)0.0006
    Infarct1/13 (8)7/11 (64)0.02
    Hematoma3/13 (33)4/11 (36)0.66
Conventional angiogram
  No. lesions (range)12 (3–28)10 (4–28)0.57
  No. territories (range)5 (2–7)5 (2–7)0.97
  String of beads appearance, %59 (11–100)27 (0–83)0.01
Vascular followup imaging0.005
  Unchanged/worsened0 (0)5 (45)
  Improved9 (70)2 (18)
  Undetermined4 (30)5 (36)
  • cSAH: cortical subarachnoid hemorrhage; CSF: cerebrospinal fluid; WBC: white blood cells; MRI: magnetic resonance imaging.